Sector portfolio · VC firm · United States

Fidelity's Biotech portfolio

Fidelity has backed 72 Biotech startups in rounds we track, $15B between them, shown by the stage each has reached. The best-funded is 23andme.

72startups backed
4stages
$15Braised between them
Series Bbiggest stage

Fidelity's whole portfolioFidelity's profile

Series B

30

+6 more

Series C and later

19

Stage not reported

18

Series A

5

Segment by segment

Series B

30 startups · $6.4B raised

  1. BBioNTechGermany$687M
  2. Intellia TherapeuticsIntellia Therapeutics is a genome editing company that develops curative gene-editing treatments.United States$485M
  3. CTCidara TherapeuticsCidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics.United States$463M
  4. LarondeLaronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.United States$440M
  5. Wave Life SciencesWave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling United States$434M
  6. Editas MedicineEditas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.United States$335M
  7. Fulcrum TherapeuticsFulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.United States$310M
  8. Quell TherapeuticsQuell Therapeutics is a cell therapy companyUnited Kingdom$274M

Series C and later

19 startups · $4.7B raised

  1. 23andMeUnited States$729M
  2. ModernaLearn how we’re changing the world of medicine.United States$675M
  3. ElevateBioElevateBio is a biotechnology company based in Waltham, Massachusetts, founded in 2017.United States$551M
  4. AdvanCellAdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.Australia$438M
  5. Outset MedicalOutset Medical is a medical technology company that offers reimagining dialysis for patients and providers.United States$360M
  6. KryKry is a leading digital healthcare provider based in Sweden, founded in 2015 by Johannes Schildt.Sweden$249M
  7. LifeMine TherapeuticsLifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.United States$230M
  8. AntengeneAntengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.China$217M

Stage not reported

18 startups · $3.0B raised

  1. NuvalentNuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.United States$500M
  2. Century TherapeuticsCentury Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.United States$385M
  3. Monte Rosa TherapeuticsMonte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.Switzerland$300M
  4. Vera TherapeuticsVera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.United States$261M
  5. Rapport TherapeuticsRapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.United States$250M
  6. Roivant SciencesRoivant aims to improve health by rapidly delivering innovative medicines and technologies to patients.United States$230M
  7. 10X Genomics10X Genomics ELV solutions and security systems company that provides an innovative genomics platform.United States$215M
  8. IInscriptaUnited States$205M

Series A

5 startups · $1.2B raised

  1. Nuvation BioNuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.United States$675M
  2. Treeline BiosciencesTreeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.United States$200M
  3. GTGemini TherapeuticsGemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.United States$138M
  4. Codiak BiosciencesCodiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.United States$100M
  5. Shoulder InnovationsShoulder Innovations is a medical device company that develops inset glenoid fixation technology.United States$49M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Fidelity as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioFidelity's AI portfolio44 startups · $522BSector portfolioFidelity's Fintech portfolio20 startups · $10BSector portfolioFidelity's Healthtech portfolio10 startups · $7.0BCo-investorsWho invests with Fidelity349 co-investorsPortfolio mapFidelity portfolio map196 startups · $618BSector portfolioTechstars' AI portfolio336 startups · $4.9B

Raising from investors like Fidelity?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps